Gland Pharma

Market Cap: Small Cap
Industry: Pharmaceuticals & Biotechnology
ISIN: INE068V01023
NSEID: GLAND
BSEID: 543245

INR

1,674.25

8.35 (0.5%)

BSENSE

Dec 19

BSE+NSE Vol: 1.13 lacs

{
  "main_header": {
    "sid": 1003443,
    "name": "Gland Pharma",
    "stock_name": "Gland Pharma",
    "full_name": "Gland Pharma Ltd",
    "name_url": "stocks-analysis/gland-pharma",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "1,674.25",
    "chg": 8.35,
    "chgp": "0.5%",
    "dir": 1,
    "prev_price": "1,665.90",
    "mcapval": "27,837.00 Cr",
    "mcap": "Small Cap",
    "scripcode": 543245,
    "symbol": "GLAND",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "",
    "isin": "INE068V01023",
    "curr_date": "Dec 19",
    "curr_time": "",
    "bse_nse_vol": "1.13 lacs",
    "exc_status": "Active",
    "traded_date": "Dec 19, 2025",
    "traded_date_str": "2025 12 19",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/gland-pharma-1003443-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Gland Pharma Technical Momentum Shifts Amid Mixed Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/gland-pharma-technical-momentum-shifts-amid-mixed-market-signals-3762007",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/GlandPharma_technicaldot_3762007.png",
        "date": "2025-12-18 08:15:05",
        "description": "Gland Pharma’s recent market activity reflects a nuanced shift in technical momentum, with a blend of bearish and bullish signals emerging across key indicators. The stock’s price movement and technical parameters suggest a transition from a sideways trend to a mildly bearish stance, underscoring a complex market assessment for this Pharmaceuticals & Biotechnology player."
      },
      {
        "title": "Gland Pharma's Market Assessment Reflects Mixed Signals Amidst Flat Financials",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/gland-pharma-upgraded-to-hold-as-technicals-improve-amid-mixed-financials-3760864",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/GlandPharma_mojoScore_3760864.png",
        "date": "2025-12-17 08:23:14",
        "description": "Gland Pharma's recent market evaluation reveals a nuanced picture shaped by a combination of technical indicators, valuation metrics, financial trends, and quality parameters. Despite flat quarterly financial performance and subdued long-term growth, shifts in technical trends and institutional confidence have influenced the current market assessment of this pharmaceutical and biotechnology company."
      },
      {
        "title": "Gland Pharma Technical Momentum Shifts Amid Mixed Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/gland-pharma-technical-momentum-shifts-to-sideways-amid-mixed-indicator-signals-3760795",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/GlandPharma_technicaldot_3760795.png",
        "date": "2025-12-17 08:15:27",
        "description": "Gland Pharma's stock has exhibited a notable shift in technical momentum, moving from a mildly bearish trend to a sideways pattern, reflecting a complex interplay of technical indicators. This development comes amid a backdrop of mixed signals from key momentum and volume indicators, suggesting a period of consolidation for the pharmaceutical company’s shares."
      },
      {
        "title": "Is Gland Pharma technically bullish or bearish?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-gland-pharma-technically-bullish-or-bearish-3747947",
        "imagepath": "",
        "date": "2025-12-05 08:48:15",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Technical Trend Overview</strong></p>\n<p>As of 04 Dec 2025, Gland Pharma's technical trend has transitioned from a sideways pattern to a mildly bearish stance. This shift is underscored by a confluence of technical indicators that predominantly signal caution. The weekly and monthly Moving Average Convergence Divergence (MACD) readings both indicate mild bearishness, suggesting that momentum is waning over these timeframes.</p>\n<p>Further reinforcing this view, the Bollinger Bands on weekly and monthly charts are bearish, implying that the stock price is trending towards the lower band, often interpreted as a sign of downward pressure. The Dow Theory, a classical method of trend analysis, also aligns with this mildly bearish outlook on both weekly and monthly scales.</p>\n<p>However, the dail..."
      },
      {
        "title": "Gland Pharma’s Market Assessment Reflects Mixed Financial and Technical Signals",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/gland-pharma-downgraded-to-sell-amid-technical-weakness-and-valuation-concerns-3747934",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/GlandPharma_mojoScore_3747934.png",
        "date": "2025-12-05 08:16:30",
        "description": "Gland Pharma’s recent market evaluation reveals a nuanced picture shaped by shifts in technical indicators, valuation metrics, financial trends, and overall quality parameters. The pharmaceutical company’s stock performance and underlying fundamentals have prompted a revision in market assessment, reflecting both challenges and areas of stability amid evolving sector dynamics."
      },
      {
        "title": "Gland Pharma Technical Momentum Shifts Amid Mixed Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/gland-pharma-faces-mildly-bearish-momentum-amid-technical-downgrade-3747809",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/GlandPharma_technicaldot_3747809.png",
        "date": "2025-12-05 08:10:57",
        "description": "Gland Pharma’s recent trading activity reveals a shift in technical momentum, with a transition from a sideways trend to a mildly bearish stance. This change is underscored by a combination of technical indicators including MACD, RSI, moving averages, and Bollinger Bands, reflecting a nuanced market assessment for the pharmaceutical sector player."
      },
      {
        "title": "How has been the historical performance of Gland Pharma?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/how-has-been-the-historical-performance-of-gland-pharma-3747134",
        "imagepath": "",
        "date": "2025-12-04 22:53:17",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Revenue and Profitability Trends</strong></p>\n<p>Gland Pharma’s net sales have shown a robust upward trend from ₹2,633.24 crores in March 2020 to ₹5,616.50 crores in March 2025, effectively more than doubling over this period. The company experienced a notable surge between March 2022 and March 2024, with sales peaking at ₹5,664.72 crores in March 2024 before a slight dip in the latest fiscal year. Despite this minor decline, the overall revenue trajectory remains positive, reflecting strong market demand and operational scale.</p>\n<p>Operating profit margins, excluding other income, have moderated from a high of 37.61% in March 2021 to 22.59% in March 2025. This contraction suggests rising costs or pricing pressures, although the company maintained a healthy operating profit of ₹1,268.92 cr..."
      },
      {
        "title": "Gland Pharma Technical Momentum Shifts Amid Mixed Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/gland-pharma-technical-momentum-shifts-amid-market-underperformance-3740397",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/GlandPharma_technicaldot_3740397.png",
        "date": "2025-12-02 08:12:06",
        "description": "Gland Pharma’s recent trading activity reflects a nuanced shift in technical momentum, with key indicators signalling a transition from a mildly bearish stance to a more sideways trend. This development comes amid a backdrop of mixed signals from moving averages, MACD, RSI, and other technical tools, offering investors a complex picture of the stock’s near-term trajectory."
      },
      {
        "title": "Gland Pharma Technical Momentum Shifts Amid Mixed Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/gland-pharma-technical-momentum-shifts-amid-mixed-market-signals-3737545",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/GlandPharma_technicaldot_3737545.png",
        "date": "2025-12-01 08:04:50",
        "description": "Gland Pharma’s recent technical indicators reveal a nuanced shift in price momentum, reflecting a transition from a sideways trend to a mildly bearish stance. While some metrics suggest caution, others indicate pockets of resilience, underscoring the complexity of the stock’s current market behaviour within the Pharmaceuticals & Biotechnology sector."
      }
    ],
    "total": 308,
    "sid": "1003443",
    "stock_news_url": "https://www.marketsmojo.com/news/gland-pharma-1003443"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
      "datetime": "12-Dec-2025",
      "details": "Schedule of Investor Meet",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
      "datetime": "11-Dec-2025",
      "details": "Schedule of Investor Meet",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
      "datetime": "08-Dec-2025",
      "details": "Schedule of Investor Meet Intimation",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Gland Pharma Ltd has declared <strong>1800%</strong> dividend, ex-date: 14 Aug 25",
          "dt": "2025-08-14",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Gland Pharma Technical Momentum Shifts Amid Mixed Market Signals

2025-12-18 08:15:05

Gland Pharma’s recent market activity reflects a nuanced shift in technical momentum, with a blend of bearish and bullish signals emerging across key indicators. The stock’s price movement and technical parameters suggest a transition from a sideways trend to a mildly bearish stance, underscoring a complex market assessment for this Pharmaceuticals & Biotechnology player.

Gland Pharma's Market Assessment Reflects Mixed Signals Amidst Flat Financials

2025-12-17 08:23:14

Gland Pharma's recent market evaluation reveals a nuanced picture shaped by a combination of technical indicators, valuation metrics, financial trends, and quality parameters. Despite flat quarterly financial performance and subdued long-term growth, shifts in technical trends and institutional confidence have influenced the current market assessment of this pharmaceutical and biotechnology company.

Gland Pharma Technical Momentum Shifts Amid Mixed Market Signals

2025-12-17 08:15:27

Gland Pharma's stock has exhibited a notable shift in technical momentum, moving from a mildly bearish trend to a sideways pattern, reflecting a complex interplay of technical indicators. This development comes amid a backdrop of mixed signals from key momentum and volume indicators, suggesting a period of consolidation for the pharmaceutical company’s shares.

Is Gland Pharma technically bullish or bearish?

2025-12-05 08:48:15

Technical Trend Overview

As of 04 Dec 2025, Gland Pharma's technical trend has transitioned from a sideways pattern to a mildly bearish stance. This shift is underscored by a confluence of technical indicators that predominantly signal caution. The weekly and monthly Moving Average Convergence Divergence (MACD) readings both indicate mild bearishness, suggesting that momentum is waning over these timeframes.

Further reinforcing this view, the Bollinger Bands on weekly and monthly charts are bearish, implying that the stock price is trending towards the lower band, often interpreted as a sign of downward pressure. The Dow Theory, a classical method of trend analysis, also aligns with this mildly bearish outlook on both weekly and monthly scales.

However, the dail...

Gland Pharma’s Market Assessment Reflects Mixed Financial and Technical Signals

2025-12-05 08:16:30

Gland Pharma’s recent market evaluation reveals a nuanced picture shaped by shifts in technical indicators, valuation metrics, financial trends, and overall quality parameters. The pharmaceutical company’s stock performance and underlying fundamentals have prompted a revision in market assessment, reflecting both challenges and areas of stability amid evolving sector dynamics.

Gland Pharma Technical Momentum Shifts Amid Mixed Market Signals

2025-12-05 08:10:57

Gland Pharma’s recent trading activity reveals a shift in technical momentum, with a transition from a sideways trend to a mildly bearish stance. This change is underscored by a combination of technical indicators including MACD, RSI, moving averages, and Bollinger Bands, reflecting a nuanced market assessment for the pharmaceutical sector player.

How has been the historical performance of Gland Pharma?

2025-12-04 22:53:17

Revenue and Profitability Trends

Gland Pharma’s net sales have shown a robust upward trend from ₹2,633.24 crores in March 2020 to ₹5,616.50 crores in March 2025, effectively more than doubling over this period. The company experienced a notable surge between March 2022 and March 2024, with sales peaking at ₹5,664.72 crores in March 2024 before a slight dip in the latest fiscal year. Despite this minor decline, the overall revenue trajectory remains positive, reflecting strong market demand and operational scale.

Operating profit margins, excluding other income, have moderated from a high of 37.61% in March 2021 to 22.59% in March 2025. This contraction suggests rising costs or pricing pressures, although the company maintained a healthy operating profit of ₹1,268.92 cr...

Gland Pharma Technical Momentum Shifts Amid Mixed Market Signals

2025-12-02 08:12:06

Gland Pharma’s recent trading activity reflects a nuanced shift in technical momentum, with key indicators signalling a transition from a mildly bearish stance to a more sideways trend. This development comes amid a backdrop of mixed signals from moving averages, MACD, RSI, and other technical tools, offering investors a complex picture of the stock’s near-term trajectory.

Gland Pharma Technical Momentum Shifts Amid Mixed Market Signals

2025-12-01 08:04:50

Gland Pharma’s recent technical indicators reveal a nuanced shift in price momentum, reflecting a transition from a sideways trend to a mildly bearish stance. While some metrics suggest caution, others indicate pockets of resilience, underscoring the complexity of the stock’s current market behaviour within the Pharmaceuticals & Biotechnology sector.